aGvH Archives - MaaT Pharma

Press Releases

November 4, 2025: MaaT Pharma Reports Financial Results for the Third Quarter 2025 and Provides Financing Update

MaaT Pharma Reports Financial Results for the Third Quarter 2025 and Provides Financing Update The…

MaaT PharmaNovember 4, 2025

Press Releases

October 15, 2024: MaaT Pharma Completes Recruitment of its ARES Phase 3 Trial for MaaT013 to Treat Acute Graft-versus-Host Disease

MaaT Pharma Completes Recruitment of its ARES Phase 3 Trial for MaaT013 to Treat Acute…

MaaT PharmaOctober 15, 2024

Press Releases

April 22, 2024: MaaT Pharma to Hold Annual General Meeting on May 28, 2024

MaaT Pharma to Hold Annual General Meeting on May 28, 2024 Lyon, France, April 22nd…

MaaT PharmaApril 22, 2024

© 2026 MaaT Pharma. MaaT Pharma’s mission is to restore microbiome function to treat life-threatening diseases

MaaT Pharma dans les médias MaaT Pharma in the News Devenez membre du club Become a member of the club